FGF23 and chronic kidney disease: our objectives are to 1) assess for systematic differences in FGF23 levels in HIV-positive and HIV-negative subjects without clinically decreased kidney function, 2) assess factors associated with FGF23 levels, and 3) evaluate associations of FGF23 levels with cross-sectional and longitudinal indicators of CKD and CVD in HIV-positive participants.